FDA Clears Emerging Digital Tomosynthesis System

FDA Clears Emerging Digital Tomosynthesis System

The Nanox.ARC X system reportedly provides enhanced 3D imaging for a variety of indications, ranging from pulmonary imaging and intra-abdominal views to musculoskeletal assessment.

Nanox Receives FDA Clearance For General Use Of New Imaging System, Nanox.ARC X - Medical Device News Magazine

First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indications. The enhanced imaging system features sleek design with smaller footprint; simplified ‘plug and play’ installation process and the system design enables software upgrades and new capabilities to be added remotely following future regulatory clearances